Try the Demo today!
| SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
|---|---|---|---|---|---|---|---|---|
| 06-Oct-20 5:23 PM View:  | Arcutis Biotherapeutics, Inc. (ARQT) | 02-Oct-20 | Purchase | 496,000 | $25.00 | $12,400,000.00 | 11% 4.67M to 5.17M | |
| 04-Feb-20 5:27 PM View: | Arcutis Biotherapeutics, Inc. (ARQT) | 04-Feb-20 | Conversion | 4,114,960 | -- | -- | 736% 558.89K to 4.67M | |
| 04-Feb-20 5:27 PM View: | Arcutis Biotherapeutics, Inc. (ARQT) | 03-Feb-20 | Purchase | 558,888 | $17.00 | $9,501,100.00 | 100% 0 to 558.89K | |
| 25-Nov-19 4:36 PM View: | Avedro Inc (AVDR) | 21-Nov-19 | Disposition | 4,240,130 | -- | -- | (100%) 4.24M to 0 | |
| 19-Feb-19 7:18 PM View: | Avedro Inc (AVDR) | 19-Feb-19 | Conversion Duplicate | 4,087,710 | -- | -- | 2682% 152.42K to 4.24M | |
| 06-Mar-18 7:41 PM View: | Glaukos Corp (GKOS) | 06-Mar-18 | Market Sale Duplicate | 161,321 | $30.70 | $4,953,270.00 | (100%) 161.32K to 0 | (144%) |
| 06-Mar-18 7:41 PM View: | Glaukos Corp (GKOS) | 05-Mar-18 | Market Sale Duplicate | 210,596 | $32.44 | $6,831,700.00 | (57%) 371.92K to 161.32K | (131%) |
| 06-Mar-18 7:41 PM View: | Glaukos Corp (GKOS) | 02-Mar-18 | Market Sale Duplicate | 464,583 | $32.29 | $15,002,200.00 | (56%) 836.5K to 371.92K | (132%) |
| 30-Jan-18 6:42 PM View: | Adicet Bio, Inc. (ACET) | 30-Jan-18 | Conversion Duplicate | 4,297,050 | -- | -- | 100% 0 to 4.3M | |
| 30-Jan-18 6:42 PM View: | Adicet Bio, Inc. (ACET) | 30-Jan-18 | Purchase Duplicate | 533,333 | $15.00 | $8,000,000.00 | 12% 4.3M to 4.83M | |
| 21-Nov-17 7:17 PM View: | Scpharmaceuticals Inc. (SCPH) | 21-Nov-17 | Conversion Duplicate | 2,576,530 | -- | -- | 100% 0 to 2.58M | |
| 05-Sep-17 9:21 PM View: | Glaukos Corp (GKOS) | 05-Sep-17 | Market Sale | 425,200 | $39.09 | $16,621,700.00 | (34%) 1.26M to 836.5K | (92%) |
| 05-Sep-17 9:21 PM View: | Glaukos Corp (GKOS) | 01-Sep-17 | Market Sale | 110,078 | $37.72 | $4,152,140.00 | (8%) 1.37M to 1.26M | (98%) |
| 05-Sep-17 9:21 PM View: | Glaukos Corp (GKOS) | 31-Aug-17 | Market Sale | 44,922 | $37.82 | $1,698,950.00 | (3%) 1.42M to 1.37M | (98%) |
| 17-Aug-17 5:27 PM View: | Glaukos Corp (GKOS) | 17-Aug-17 | Market Sale Duplicate | 226,920 | $37.85 | $8,588,920.00 | (14%) 1.64M to 1.42M | (98%) |
| 17-Aug-17 5:27 PM View: | Glaukos Corp (GKOS) | 16-Aug-17 | Market Sale Duplicate | 65,580 | $38.01 | $2,492,700.00 | (4%) 1.71M to 1.64M | (97%) |
| 17-Aug-17 5:27 PM View: | Glaukos Corp (GKOS) | 15-Aug-17 | Market Sale Duplicate | 32,500 | $38.29 | $1,244,420.00 | (2%) 1.74M to 1.71M | (96%) |
| 14-Mar-17 7:47 PM View: | Glaukos Corp (GKOS) | 14-Mar-17 | Market Sale Duplicate | 74,100 | $44.54 | $3,300,410.00 | (4%) 1.82M to 1.74M | (68%) |
| 14-Mar-17 7:47 PM View: | Glaukos Corp (GKOS) | 13-Mar-17 | Market Sale Duplicate | 211,410 | $45.30 | $9,577,450.00 | (10%) 2.03M to 1.82M | (65%) |
| 14-Mar-17 7:47 PM View: | Glaukos Corp (GKOS) | 10-Mar-17 | Market Sale Duplicate | 97,028 | $45.98 | $4,461,350.00 | (5%) 2.12M to 2.03M | (63%) |
| 07-Mar-17 6:52 PM View: | Glaukos Corp (GKOS) | 03-Mar-17 | Market Sale Duplicate | 55,772 | $47.05 | $2,624,070.00 | (3%) 2.18M to 2.12M | (59%) |
| 12-Aug-16 8:22 PM View: | Glaukos Corp (GKOS) | 12-Aug-16 | Market Sale | 14,100 | $33.72 | $475,452.00 | (< 1%) 2.19M to 2.18M | (122%) |
| 12-Aug-16 8:22 PM View: | Glaukos Corp (GKOS) | 11-Aug-16 | Market Sale | 160,900 | $33.63 | $5,411,070.00 | (7%) 2.35M to 2.19M | (123%) |
| 12-Aug-16 8:22 PM View: | Glaukos Corp (GKOS) | 10-Aug-16 | Market Sale | 117,938 | $33.77 | $3,982,770.00 | (5%) 2.47M to 2.35M | (122%) |
| 05-Aug-16 4:11 PM View: | Glaukos Corp (GKOS) | 03-Aug-16 | Market Sale Duplicate | 425,000 | $30.59 | $13,000,800.00 | (15%) 2.9M to 2.47M | (145%) |
| 25-Jul-16 5:08 PM View: | Audentes Therapeutics, Inc. (BOLD) | 25-Jul-16 | Conversion Duplicate | 4,544,070 | -- | -- | 2026% 224.23K to 4.77M | |
| 25-Jul-16 5:08 PM View: | Audentes Therapeutics, Inc. (BOLD) | 25-Jul-16 | Purchase Duplicate | 33,334 | $15.00 | $500,010.00 | < 1% 4.77M to 4.8M | |
| 27-Nov-15 9:02 PM View: | Intercept Pharmaceuticals, ... (ICPT) | 24-Nov-15 | Grant | 650 | -- | -- | < 1% 1.12M to 1.12M | |
| 30-Jun-15 6:13 PM View: | Glaukos Corp (GKOS) | 30-Jun-15 | Conversion Duplicate | 2,882,060 | -- | -- | 100% 0 to 2.88M | |
| 30-Jun-15 6:13 PM View: | Glaukos Corp (GKOS) | 30-Jun-15 | Payment of Exercise Duplicate | 11,734 | $18.00 | $211,212.00 | (< 1%) 2.91M to 2.9M | |
| 30-Jun-15 6:13 PM View: | Glaukos Corp (GKOS) | 30-Jun-15 | Option Exercise Duplicate | 27,607 | -- | -- | < 1% 2.88M to 2.91M | |
| 30-Mar-15 3:59 PM View: | Intercept Pharmaceuticals, ... (ICPT) | 26-Mar-15 | Market Sale Duplicate | 157,200 | $286.75 | $45,076,400.00 | (12%) 1.28M to 1.12M | 91% |
| 25-Mar-15 7:34 PM View: | Intercept Pharmaceuticals, ... (ICPT) | 25-Mar-15 | Market Sale Duplicate | 2,800 | $270.23 | $756,644.00 | (< 1%) 1.28M to 1.28M | 90% |
| 25-Mar-15 7:34 PM View: | Intercept Pharmaceuticals, ... (ICPT) | 24-Mar-15 | Market Sale Duplicate | 45,600 | $272.00 | $12,403,000.00 | (3%) 1.33M to 1.28M | 90% |
| 25-Mar-15 7:34 PM View: | Intercept Pharmaceuticals, ... (ICPT) | 23-Mar-15 | Market Sale Duplicate | 159,400 | $275.18 | $43,863,100.00 | (11%) 1.49M to 1.33M | 90% |
| 27-Aug-14 9:06 PM View: | Intercept Pharmaceuticals, ... (ICPT) | 26-Aug-14 | Market Sale Duplicate | 61,258 | $300.07 | $18,381,600.00 | (4%) 1.55M to 1.49M | 91% |
| 27-Aug-14 9:06 PM View: | Intercept Pharmaceuticals, ... (ICPT) | 25-Aug-14 | Market Sale Duplicate | 50,000 | $295.59 | $14,779,500.00 | (3%) 1.6M to 1.55M | 91% |
| 18-Aug-14 9:13 PM View: | Intercept Pharmaceuticals, ... (ICPT) | 14-Aug-14 | Market Sale Duplicate | 60,000 | $299.82 | $17,989,200.00 | (4%) 1.66M to 1.6M | 91% |
| 12-Aug-14 9:05 PM View: | Intercept Pharmaceuticals, ... (ICPT) | 09-Aug-14 | Option Exercise | 324 | -- | -- | < 1% 1.66M to 1.66M | |
| 24-Jul-14 5:09 PM View: | Roka Bioscience, Inc. (ROKA) | 22-Jul-14 | Conversion Duplicate | 2,832,360 | -- | -- | 59855% 4.74K to 2.84M | |
| 24-Jul-14 5:09 PM View: | Roka Bioscience, Inc. (ROKA) | 22-Jul-14 | Purchase Duplicate | 383,333 | $12.00 | $4,600,000.00 | 14% 2.84M to 3.22M | |
| 21-Jul-14 9:02 PM View: | Intercept Pharmaceuticals, ... (ICPT) | 17-Jul-14 | Grant | 285 | -- | -- | < 1% 1.66M to 1.66M | |
| 09-May-14 9:04 PM View: | Intercept Pharmaceuticals, ... (ICPT) | 09-May-14 | Option Exercise | 325 | -- | -- | < 1% 1.66M to 1.66M | |
| 11-Apr-14 9:00 PM View: | Intercept Pharmaceuticals, ... (ICPT) | 09-Apr-14 | Private Sale Duplicate | 81,305 | $320.00 | $26,017,600.00 | (5%) 1.74M to 1.66M | |
| 11-Feb-14 9:01 PM View: | Intercept Pharmaceuticals, ... (ICPT) | 09-Feb-14 | Option Exercise | 324 | -- | -- | < 1% 1.74M to 1.74M | |
| 20-Nov-13 7:31 PM View: | Relypsa Inc (RLYP) | 20-Nov-13 | Conversion Duplicate | 7,511,930 | -- | -- | 100% 0 to 7.51M | |
| 20-Nov-13 7:31 PM View: | Relypsa Inc (RLYP) | 20-Nov-13 | Payment of Exercise Duplicate | 27,282 | $11.00 | $300,102.00 | (< 1%) 9.97M to 9.94M | |
| 20-Nov-13 7:31 PM View: | Relypsa Inc (RLYP) | 20-Nov-13 | Option Exercise Duplicate | 1,744,710 | $0.17 | $296,601.00 | 23% 7.51M to 9.26M | |
| 20-Nov-13 7:31 PM View: | Relypsa Inc (RLYP) | 20-Nov-13 | Purchase Duplicate | 712,192 | $11.00 | $7,834,110.00 | 8% 9.26M to 9.97M | |
| 12-Nov-13 9:31 PM View: | Intercept Pharmaceuticals, ... (ICPT) | 09-Nov-13 | Option Exercise | 325 | -- | -- | < 1% 1.74M to 1.74M |